论文部分内容阅读
目的:评价阿奇霉素对肺炎支原体致下呼吸道感染患者的临床疗效。方法:选取2013年3月—2015年11月间收治的肺炎支原体下呼吸道感染患者71例临床资料,根据治疗方式的不同将其分为对照组35和观察组36例;对照组患者予以止咳平喘、吸氧支持、化痰、营养支持、阿奇霉素等常规治疗,观察组患者在对照组基础上加用地塞米松片治疗,观察两组患者治疗后的总有效率和临床症状各指标复常时间。结果:观察组患者治疗后的总有效率为94.44%高于对照组为71.43%(P<0.05),咳嗽消失时间、体温复常时间、X线胸片阴影复常时间和住院时间均优于对照组(P<0.05)。结论:阿奇霉素对肺炎支原体致下呼吸道感染患者的临床疗效较为突出,临床症状各指标复常时间较快。
Objective: To evaluate the clinical efficacy of azithromycin in patients with lower respiratory tract infection caused by Mycoplasma pneumoniae. Methods: The clinical data of 71 patients with Mycoplasma pneumoniae lower respiratory tract infection who were admitted from March 2013 to November 2015 were selected and divided into control group 35 and observation group 36 according to the different treatment methods. Patients in the control group were given cough flat Asthma, oxygen support, phlegm, nutritional support, azithromycin and other conventional treatment, the observation group patients on the basis of the control group plus dexamethasone tablets treatment, the two groups were observed after the treatment of the total effective rate and clinical symptoms of each index of the normal time . Results: The total effective rate of the observation group after treatment was 94.44%, which was significantly higher than that of the control group (71.43%, P <0.05). The cough disappearance time, body temperature recovery time, X-ray chest shadow time and hospital stay were all better Control group (P <0.05). Conclusion: The clinical efficacy of azithromycin in patients with lower respiratory tract infection caused by Mycoplasma pneumoniae is more prominent, and the clinical symptoms and signs are faster in patients with recurrent respiratory tract infections.